North America Travel Vaccines Market
The North America Travel Vaccines Market size was valued at US$ 1,276.32 Mn in 2021 and is projected to reach US$ 2,503.59 Mn by 2028, growing at a CAGR of 10.1% during 2021 - 2028.
Report Coverage
- Product: Hepatitis A, Hepatitis B, Meningococcal Vaccines
- Application: Domestic Travel and Outbound Travel
US$ 1,276.32 Mn
Market size in 2021
US$ 2,503.59 Mn
Market Size by 2028
10.1%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Travel Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Travel Vaccines Market Regional Analysis
6.2 North America Travel Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 North America Travel Vaccines Market Forecast Analysis
7. North America Travel Vaccines Market Analysis – by Product
7.1 Hepatitis A
- 7.1.1 Overview
- 7.1.2 Hepatitis A: North America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Hepatitis B
- 7.2.1 Overview
- 7.2.2 Hepatitis B: North America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Meningococcal Vaccines
- 7.3.1 Overview
- 7.3.2 Meningococcal Vaccines: North America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Travel Vaccines Market Analysis – by Application
8.1 Domestic Travel and Outbound Travel
- 8.1.1 Overview
- 8.1.2 Domestic Travel and Outbound Travel : North America Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Travel Vaccines Market – North America Analysis
9.1 Overview
9.2 North America- 9.2.1 North America Travel Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
- 9.2.1.1 North America Travel Vaccines Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Travel Vaccines Market Breakdown, by Product
- 9.2.1.1.2 US: North America Travel Vaccines Market Breakdown, by Application
- 9.2.1.2 Canada: North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Travel Vaccines Market Breakdown, by Product
- 9.2.1.2.2 Canada: North America Travel Vaccines Market Breakdown, by Application
- 9.2.1.3 Mexico : North America Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Travel Vaccines Market Breakdown, by Product
- 9.2.1.3.2 Mexico : North America Travel Vaccines Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Dynavax Technologies
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emergent BioSolutions Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GlaxoSmithKline plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merck & Co., Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Novartis AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pfizer Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Sanofi
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Valneva SE.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
